LEA LEIV
Insider CIK 939012 · CRVS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2025-12-04 | 2025-12-08 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2024-12-20 | 2024-12-23 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2023-12-06 | 2023-12-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-12-14 | 2022-12-15 | 4,000 | $0.84 | $3.4K | 133,238 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-12-13 | 2022-12-15 | 30,000 | $0.74 | $22.2K | 129,238 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2022-08-11 | 2022-08-15 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-03-17 | 2022-03-17 | 13,878 | $1.65 | $22.9K | 99,238 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-03-16 | 2022-03-17 | 35,160 | $1.54 | $54.1K | 85,360 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2021-09-09 | 2021-09-13 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2020-12-16 | 2020-12-17 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2019-12-12 | 2019-12-16 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-06-07 | 2019-06-10 | 10,000 | $3.38 | $33.8K | 50,200 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-06-06 | 2019-06-10 | 15,500 | $3.56 | $55.2K | 40,200 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2018-12-21 | 2018-12-27 | 24,700 | $4.15 | $102.5K | 24,700 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2018-12-12 | 2018-12-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2017-12-13 | 2017-12-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2016-12-07 | 2016-12-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion deriv | 2016-03-29 | 2016-03-29 | 42,608 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion | 2016-03-29 | 2016-03-29 | 42,608 | — | $0 | 199,253 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2016-03-22 | 2016-03-24 | 60,000 | — | $0 | 60,000 | SEC↗ |